Showing results (51-60 of 117) with videos related to
Sort By:
Pageof 12
Clinical Lung Cancer|December 10, 2021
Phase III Clinical Trial for the Combination of Erlotinib Plus Ramucirumab Compared With Osimertinib in Previously Untreated Advanced or Recurrent Non-Small Cell Lung Cancer Positive for the L858R Mutation of EGFR: REVOL858R (WJOG14420L)Naoki Haratake, Hidetoshi Hayashi, Mototsugu Shimokawa, et al.Thoracic Cancer|July 25, 2019
Short progression-free survival of ALK inhibitors sensitive to secondary mutations in ALK-positive NSCLC patientsNaoki Haratake, Takashi Seto, Shinkichi Takamori, et al.Anticancer Research|March 2, 2018
High Frequency of Spread Through Air Spaces in Resected Small Cell Lung CancerGouji Toyokawa, Yuichi Yamada, Tetsuzo Tagawa, et al.Journal of Thoracic Disease|October 29, 2019
Prognostic impact of the Controlling Nutritional Status score in patients with non-small cell lung cancer treated with pembrolizumabTaro Ohba, Shinkichi Takamori, Ryo Toyozawa, et al.Journal of Thoracic Disease|April 26, 2019
A novel prognostic marker in patients with non-small cell lung cancer: musculo-immuno-nutritional score calculated by controlling nutritional status and creatine kinaseShinkichi Takamori, Gouji Toyokawa, Mototsugu Shimokawa, et al.Journal of Thoracic Disease|December 10, 2017
Prognostic impact of controlling nutritional status score in resected lung squamous cell carcinomaGouji Toyokawa, Yuka Kozuma, Taichi Matsubara, et al.Journal of Thoracic Disease|September 22, 2017
Surgical resection of a well-differentiated inflammatory liposarcoma of the middle mediastinum: a case reportMakoto Edagawa, Naoki Haratake, Shinichiro Shimamatsu, et al.The Annals of Thoracic Surgery|December 20, 2017
Programmed Death-Ligand 1 Expression and EGFR Mutations in Multifocal Lung CancerNaoki Haratake, Gouji Toyokawa, Kazuki Takada, et al.Clinical Lung Cancer|January 1, 2017
High Frequency of Programmed Death-ligand 1 Expression in Emphysematous Bullae-associated Lung AdenocarcinomasGouji Toyokawa, Kazuki Takada, Tatsuro Okamoto, et al.Transplant Immunology|December 4, 2018
HMGB1 blockade significantly improves luminal fibrous obliteration in a murine model of bronchiolitis obliterans syndromeShinkichi Takamori, Fumihiro Shoji, Tatsuro Okamoto, et al.Pageof 12